Clik here to view.
Genocea HSV-2 Immunotherapeutic GEN-003 Elicits Significant, Durable T Cell...
CAMBRIDGE, Mass. Genocea Biosciences, Inc. (NASDAQ:GNCA), a clinical-stage biopharmaceutical company developing T cell-enabled vaccines and immunotherapies, today presented data from a Phase 1/2a...
View ArticleClik here to view.
Seegene to Unveil at AACC 2014 the Innovative Real-Time PCR Technology That...
GAITHERSBURG, Md. & SEOUL, South Korea Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced “MuDT™” technology, the industry’s first real-time PCR...
View ArticleClik here to view.
ONCODESIGN: 1st Half of 2014
DIJON, France ONCODESIGN, a biotechnology company serving the pharmaceutical industry in the discovery of new therapeutic molecules to fight cancer and other serious illnesses with no known...
View ArticleClik here to view.
Biosceptre Announces Positive Phase I Results for BIL-010t to Treat Basal...
CAMBRIDGE, England Biosceptre, the oncology company developing antibody products that target the nf-P2X7 receptor, announces positive results from its Phase I trial to assess the safety and...
View ArticleClik here to view.
Dr. Reddy’s to Release Q1 FY15 Results on July 30, 2014
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) will announce results for the First Quarter ended June 30, 2014 on Wednesday, July 30, 2014 after the Board Meeting. The results will be...
View ArticleClik here to view.
エリテック、米国にて急性リンパ芽球性白血病を対象に ERY-ASPを検討する第 I/II 相試験で、初の患者組み入れを発表
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック・ファーマ（Paris:ERYP）（Euronext Paris: FR0011471135 – ERYP）は、米国にて急性リンパ芽球性白血病を対象に ERY-ASPを検討する第 I/II...
View ArticleClik here to view.
Personalized Chemotherapy Tests Cleared for Use in China
SHANGHAI & BETHLEHEM, Pa. Fosun Diagnostics, a division of Fosun Pharmaceuticals, and Saladax Biomedical, Inc. today announced the launch of the MyCare™ portfolio of exposure optimization tests...
View ArticleClik here to view.
Bristol-Myers Squibb and Ono Pharmaceutical Co., Ltd. Announce Strategic...
NEW YORK & OSAKA, Japan Bristol-Myers Squibb Company (NYSE:BMY) and Ono Pharmaceutical Co., Ltd. (“Ono”) have signed a strategic collaboration agreement to jointly develop and commercialize...
View ArticleClik here to view.
Gilead Announces New Agreement with Medicines Patent Pool for Access to...
MELBOURNE, Australia Gilead Sciences, Inc. (NASDAQ:GILD) announced today at the 20th International AIDS Conference in Melbourne, Australia, a new agreement with the Medicines Patent Pool (MPP) to...
View ArticleClik here to view.
The Second ‘SHINIQUE Health Journey’ of Jinchi Biotech Ltd. Was Held in...
ZHANGJIAJIE, China Jinchi Biotech Ltd., During July 10th – 12th, 2014, a group of 40 SHINIQUE VIP Customers, formed by managers of local or national beauty salon chains from all over China attended...
View ArticleClik here to view.
Harlan Provides Expertise for Biologics and Biosimilars
ITINGEN, Switzerland Harlan Laboratories, Ltd., a privately held provider of general and specialty toxicology services through its Contract Research Services (CRS) business, is prepared to meet the...
View ArticleClik here to view.
Dr. Reddy’s Q1 FY15 Financial Results
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its unaudited consolidated financial results for the quarter ended June 30, 2014 under International Financial Reporting...
View ArticleClik here to view.
Tigermed and Frontage Laboratories Complete Strategic Investment Agreement
EXTON, Pa. Hangzhou Tigermed Consulting Co., Ltd. and Frontage Laboratories, Inc. today announced completion of the previously announced investment agreement, following approval by the China...
View ArticleClik here to view.
22nd Century Group实质上消除烟草植物中尼古丁的技术获得专利
纽约州克拉伦斯 (美国商业资讯) –22nd Century Group, Inc. (NYSE MKT:XXII)今天宣布，该公司可实质上消除烟草植物中尼古丁的NBB技术，分别于2014年7月29日和2014年7月23日获得美国专利商标局(USPTO)和韩国知识产权署颁发的专利。该技术衍生的烟草植物，其种植、生长、收获、加工、处理和制备成烟草产品（包括香烟）的过程，均与常规烟草完全相同。...
View ArticleClik here to view.
Zoll Receives Shonin Approval from Japanese Ministry of Health, Labour and...
CHELMSFORD, Mass. ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that its Japanese subsidiary, Asahi Kasei ZOLL Medical (AZM), has...
View ArticleClik here to view.
Harlan提供生物制剂和生物类似物领域的专项技能
瑞士伊廷根 (美国商业资讯) — Harlan Laboratories, Ltd.是一家私有的提供商，通过其合同研究服务(CRS)业务，提供普通和专科毒理学服务，该公司已准备好满足新型生物制剂和生物类似物开发项目中的全球性需求。 在监管层对生物类似物的接纳方面，美国食品药品管理局(FDA)比欧洲药品管理局缓慢，尽管如此，Harlan...
View ArticleClik here to view.
ハーランが生物製剤とバイオシミラーの専門力を提供
スイス・イティンゲン （ビジネスワイヤ） — 受託研究サービス（CRS）事業を通じて一般的／専門的毒性検査サービスを提供する株式非公開企業のハーランラボラトリーズ・リミテッド（Harlan Laboratories, Ltd.）は、新規の生物製剤やバイオシミラーの開発プログラムに対する世界的な需要に対応できる体制にあります。...
View ArticleClik here to view.
Panasonic’s Healthcare Solutions Streamline Medical Treatment
OSAKA, Japan Under the theme of “Providing optimal healthcare for each individual,” Panasonic Healthcare Co., Ltd. showcased its latest solutions at the International Modern Hospital Show 2014,...
View ArticleClik here to view.
Catalent, Inc.宣布首次公开募股定价
新泽西萨默塞特 (美国商业资讯)–全球领先的药品、生物制剂和消费者保健产品高级交付技术和开发解决方案提供商Catalent, Inc....
View ArticleClik here to view.